"As we discussed in our second quarter conference call on
Contact: David DiGiacinto, President & Chief Operating Officer
ddigiacinto@minrad.com
Kirk Kamsler, Senior Vice President, Commercial Development
kkamsler@minrad.com
Charles R. Trego, Jr., Executive Vice President & Chief
Financial Officer
ctrego@minrad.com
(716) 855-1068
http://www.minrad.com
About the Company
MINRAD International, Inc. is an interventional pain management company with real-time image guidance, anesthesia and analgesia, conscious sedation product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. Additional information can be found at the company's website, http://www.minrad.com.
The information contained in this news release, other than historical
information, consists of forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These statements may involve
risks and uncertainties that could cause actual results to differ materially
from those described in such statements. Factors that may cause actual results
to differ materially from those expressed or implied by its forward-looking
statements include, but are not limited to, Minrad International's limited
operating history and business development associated with being a growth
stage company; its dependence on key personnel; its need to attract and retain
technical and managerial personnel; its ability to execute its business
strategy; the intense competition it faces; its ability to protect its
intellectual property and proprietary technologies; its exposure to product
liability claims resulting from the use of its products; general economic and
capital market conditions; financial conditions of its customers and their
perception of its financial condition relative to that of its competitors; as
well as those risks described under the heading "Risk Factors" of Minrad
International's Form 10-KSB/A, filed with the Securities and Exchange
Commission on
SOURCE MINRAD International, Inc.